VRSK — what changed in the latest 10-Q
A section-by-section comparison of VRSK's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-07-29 vs the prior 10-Q · 2026-04-29
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +28 | −11 | ~16 | 26 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 0 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | 0 | ~3 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-07-29
Revenues were $806.3 million for the three months ended June 30, 2026, compared to $772.6 million for the three months ended June 30, 2025, an increase of $33.7 million or 4.3 %. Our underwriting revenue increased $19.5 million or 3.5%. Our claims revenue increased $14.2 million or 6.3 %.
Selling, general and administrative expenses were $128.6 million for the three months ended June 30, 2026 compared to $106.5 million for the three months ended June 30, 2025, an increase of $22.1 million or 20.8%. Our recent acquisition, disposition, and AccuLynx related costs accounted for a net in…
Amortization of intangible assets was $14.3 million and $16.3 million for the six months ended June 30, 2026 and 2025, respectively, a decrease of $2.0 million or 12.3%. The decrease was primarily due to the disposition of VMS and certain intangible assets becoming fully amortized, partially offset …
Investment loss was $7.5 million for the three months ended June 30, 2026 compared to a gain of $9.1 million for the three months ended June 30, 2025, a change of $16.6 million. The loss for the three months ended June 30, 2026 was primarily driven by $6.5 million of loss from equity method investme…
EBITDA was $436.8 million for the three months ended June 30, 2026 compared to $445.7 million for the three months ended June 30, 2025. The EBITDA margin for our consolidated results was 54.2% for the three months ended June 30, 2026 compared to 57.7% for the three months ended June 30, 2025. The de…
Text removed vs the prior filing · source: 10-Q · 2026-04-29
Revenues were $782.6 million for the three months ended March 31, 2026, compared to $753.0 million for the three months ended March 31, 2025, an increase of $29.6 million or 3.9%. Our underwriting revenue increased $20.1 million or 3.8%. Our claims revenue increased $9.5 million or 4.3%.
Selling, general and administrative expenses were $109.5 million for the three months ended March 31, 2026 compared to $108.9 million for the three months ended March 31, 2025, an increase of $0.6 million or 0.6%. Our recent acquisitions and disposition accounted for a net decrease of $2.7 million i…
Amortization of intangible assets was $14.4 million for the three months ended March 31, 2026 and $15.8 million for the three months ended March 31, 2025, a decrease of $1.4 million or 8.9%. The decrease was primarily due to the disposition of VMS, partially offset by a $2.2 million increase due to …
Investment loss was $0.5 million for the three months ended March 31, 2026 compared to a gain of $2.6 million for the three months ended March 31, 2025, a change of $3.1 million. The loss was primarily due to the impact of foreign currencies.
EBITDA was $436.0 million for the three months ended March 31, 2026 compared to $415.9 million for the three months ended March 31, 2025. The EBITDA margin for our consolidated results was 55.7% for the three months ended March 31, 2026 compared to 55.2% for the three months ended March 31, 2025. Th…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice